JusticeSingle-source
2.1
Brazil Court Rejects Shareholder Bid to Suspend Grupo Toky Assembly Decisions
Valor Econômico·BR·about 7 hours ago
Brazil's CVM approved Oncoclínicas' R$14bn public tender offer on Aug 25, but implementation is stalled beyond the 60-day deadline as shareholders dispute arbitration legitimacy. The delay creates uncertainty for the deal's completion and may affect minority shareholder outcomes.